Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients.
暂无分享，去创建一个
F. Ducray | M. Sanson | O. Chinot | D. Figarella-Branger | C. Carpentier | F. Escande | V. Quillien | N. Entz-Werlé | D. Chiforeanu | M. Legrain | D. Meyronet | A. Lavenu | E. Vauléon | F. Fina | G. Levallet | C. Ramirez | P. Rivet | L. Karayan‐Tapon | Emmanuèle Lechapt Zalcman